Entera Bio Publishes Key Study

Oct 2020 Entera Bio Publishes Key Study Describing its Oral Delivery Technology Platform for Biologic Drugs. The Technology is utilized in Entera’s EB613 oral PTH drug for osteoporosis and several other molecules now in development by Entera and in collaboration with pharmaceutical companies. Entera Bio and the University of East Anglia in the UK published preclinical in vivo studies which demonstrate the technologies efficiency in the oral delivery of large molecule biologic drugs.

pdf Key Study